Stock IVRN INNOVEREN SCIENTIFIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets
Other stock markets
 12:21:24 2024-05-13 pm EDT 		5-day change 1st Jan Change
0.0055 USD -72.50% Intraday chart for Innoveren Scientific Inc. -72.50% -95.26%
Mar. 06 Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite CI
2023 Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 12.9 2.071 9.296 1.619
Enterprise Value (EV) 1 14.37 1.604 12.82 5.542
P/E ratio -0.38 x -0.27 x -1.73 x -0.08 x
Yield - - - -
Capitalization / Revenue 1.55 x 0.96 x 5.77 x 3.57 x
EV / Revenue 1.72 x 0.75 x 7.95 x 12.2 x
EV / EBITDA -1.15 x -0.23 x -2.55 x -1.82 x
EV / FCF -2,721,087 x -380,289 x -4,619,114 x 8,324,924 x
FCF Yield -0% -0% -0% 0%
Price to Book -1.43 x -1.7 x -1.81 x -0.17 x
Nbr of stocks (in thousands) 99.2 127 163 616
Reference price 2 130.0 16.29 56.90 2.630
Announcement Date 4/22/20 3/25/21 2/25/22 5/10/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022
Net sales 1 7.883 8.347 2.151 1.612 0.4535
EBITDA 1 -3.49 -12.53 -7.011 -5.037 -3.044
EBIT 1 -3.585 -13.36 -7.092 -5.053 -3.058
Operating Margin -45.48% -160.06% -329.77% -313.55% -674.36%
Earnings before Tax (EBT) 1 -4.394 -29.81 -6.459 -4.799 -10.3
Net income 1 -4.394 -29.81 -6.459 -4.799 -10.3
Net margin -55.74% -357.11% -300.34% -297.81% -2,271.33%
EPS 2 -130.5 -344.5 -60.82 -32.93 -35.06
Free Cash Flow - -5.281 -4.217 -2.775 0.6657
FCF margin - -63.27% -196.06% -172.22% 146.82%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 4/22/20 4/22/20 3/25/21 2/25/22 5/10/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt 1 4.42 1.47 - 3.52 3.92
Net Cash position 1 - - 0.47 - -
Leverage (Debt/EBITDA) -1.265 x -0.1173 x - -0.6994 x -1.289 x
Free Cash Flow - -5.28 -4.22 -2.78 0.67
ROE (net income / shareholders' equity) - 630% 290% 168% 147%
ROA (Net income/ Total Assets) - -448% -162% -250% -833%
Assets 1 - 6.65 3.989 1.919 1.236
Book Value Per Share 2 -169.0 -91.10 -9.560 -31.50 -15.80
Cash Flow per Share 2 2.070 14.30 12.90 0.5800 -
Capex 1 0.01 0.02 0 0.01 -
Capex / Sales 0.14% 0.25% 0.11% 0.49% -
Announcement Date 4/22/20 4/22/20 3/25/21 2/25/22 5/10/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INNOVEREN SCIENTIFIC INC. Stock Innoveren Scientific Inc.
-95.26% 29.36K
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+12.15% 227B
DANAHER CORPORATION Stock Danaher Corporation
+14.90% 197B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.22% 141B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+29.15% 110B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.53% 64.15B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+16.92% 53.72B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+6.33% 51.75B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+10.93% 45.2B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+5.87% 37.37B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. IVRN Stock
  4. Financials Innoveren Scientific Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW